The Conversation (0)
Oncolytics Biotech announced the appointment of a new member of the board of directors.
Oncolytics Biotech (TSX:ONC; OTCQX:ONCYF) announced the appointment of a new member of the board of directors.
As quoted the press release:
Announced the appointment of Deborah M. Brown, B.Sc., M.B.A., to Oncolytics’ Board of Directors.
“Ms. Brown’s wealth of experience in new product launches and market expansion will lend valuable insights as we progress REOLYSIN toward commercialization,” said Dr. Matt Coffey, President and CEO of Oncolytics Biotech. “In addition to successfully leading the launch of a blockbuster drug in a new therapeutic category, Ms. Brown has experience in regulatory affairs, research and development and business development, which will support our clinical development programs and our pursuit of research collaborations and commercialization partnerships.”
Source: www.newswire.ca